|Articles|January 16, 2023
DeepIntent Celebrates Year-Over-Year Growth as Marketers Invest in CTV
Advertisement
DeepIntent, a healthcare advertising technology company built to influence better patient health and business outcomes, announced it has reached a significant milestone, achieving growth for the fifth consecutive year and a triple-digit percentage growth rate across connected television (CTV) campaigns.
In 2022, DeepIntent experienced triple-digit growth in CTV investment on its demand side platform, making CTV one of the fastest-growing channels for the hundreds of pharmaceutical brands now using the DeepIntent Healthcare Advertising Platform.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
M&A Roundup: McKesson to Acquire Precision Medicine Group, Lundbeck & Eversana Enter AI-Powered Partnership
2
Why Integrated GMP Operating Models Are Reshaping Outsourced Manufacturing
3
Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321
4
Beyond Amyloid, Part One (of two): Tau and Microglia Redefine the Alzheimer’s Pipeline
5